NCT07235748 2026-02-17
Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants
Servier
Phase 1 Completed
Clinical Trials
5 trialsNCT05646862 2026-02-05
INAVO121
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT04634071 2026-02-02
TTOP
University of Kentucky
Phase 2 Completed
NCT03996265 2026-01-15
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
University of Rochester
Phase 3 Active not recruiting
NCT04694846 2025-09-09
Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use
Thomas Jefferson University
Phase NA Completed